These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37615282)

  • 21. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?
    Meyer MR; Maurer HH
    Anal Chim Acta; 2016 Jul; 927():13-20. PubMed ID: 27237833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MASS SPECTROMETRY ANALYSIS OF DRUGS OF ABUSE: CHALLENGES AND EMERGING STRATEGIES.
    Borden SA; Palaty J; Termopoli V; Famiglini G; Cappiello A; Gill CG; Palma P
    Mass Spectrom Rev; 2020 Sep; 39(5-6):703-744. PubMed ID: 32048319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis.
    Rotolo MC; Klein J; Pacifici R; Busardo FP; Pichini S; Marchei E
    Curr Pharm Biotechnol; 2017; 18(10):834-839. PubMed ID: 29173161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives.
    Tanna S; Ogwu J; Lawson G
    Clin Chem Lab Med; 2020 Apr; 58(5):643-663. PubMed ID: 31926065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography-mass spectrometry in forensic toxicology.
    Van Bocxlaer JF; Clauwaert KM; Lambert WE; Deforce DL; Van den Eeckhout EG; De Leenheer AP
    Mass Spectrom Rev; 2000; 19(4):165-214. PubMed ID: 10986692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of a widely-targeted metabolomics method based on gas chromatography-mass spectrometry].
    Wang YT; Yang Y; Sun XL; Ji J
    Se Pu; 2023 Jun; 41(6):520-526. PubMed ID: 37259877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control.
    Maurer HH
    Clin Chem Lab Med; 2004; 42(11):1310-24. PubMed ID: 15576292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid chromatography-mass spectrometry: potential in forensic and clinical toxicology.
    Marquet P; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):93-118. PubMed ID: 10572976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyphenated liquid chromatographic techniques in forensic toxicology.
    Bogusz MJ
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):65-91. PubMed ID: 10572975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers.
    Marchei E; Ferri MA; Torrens M; Farré M; Pacifici R; Pichini S; Pellegrini M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology.
    Peters FT
    Clin Biochem; 2011 Jan; 44(1):54-65. PubMed ID: 20709050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced hyphenated chromatographic-mass spectrometry in mycotoxin determination: current status and prospects.
    Li P; Zhang Z; Hu X; Zhang Q
    Mass Spectrom Rev; 2013; 32(6):420-52. PubMed ID: 23804155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The general toxicology unknown. I. The systematic approach.
    Wu Chen NB; Schaffer MI; Lin RL; Kurland ML; Donoghue ER; Stein RJ
    J Forensic Sci; 1983 Apr; 28(2):391-7. PubMed ID: 6345717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Maurer HH
    Anal Bioanal Chem; 2007 Aug; 388(7):1315-25. PubMed ID: 17377775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid chromatography-mass spectrometry in forensic and clinical toxicology.
    Maurer HH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):3-25. PubMed ID: 9700550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyphenated high-resolution mass spectrometry-the "all-in-one" device in analytical toxicology?
    Maurer HH
    Anal Bioanal Chem; 2021 Apr; 413(9):2303-2309. PubMed ID: 33247339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid Chromatography-Tandem Mass Spectrometry: An Emerging Technology in the Toxicology Laboratory.
    Zhang YV; Wei B; Zhu Y; Zhang Y; Bluth MH
    Clin Lab Med; 2016 Dec; 36(4):635-661. PubMed ID: 27842783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.